CNC — Centene Corporation stock price and chart

CNC

$68.71+1.00%

as of close, Oct 27, 2026

☾ AH $68.71 +1.00%

Centene CorporationStock · HealthcareS&P 500 Equal Weight · 0.2% of RSPS&P 500 · 0.05% of SPYRussell 1000 · 0.05% of IWBUS Stock Market · 0.04% of VTIRussell 3000 · 0.04% of IWVMSCI World · 0.03% of URTHMSCI ACWI · 0.03% of ACWI

PeersCIHUMELVMOHCVSOSCR

Share this page

Technical analysis2

Overlay lines0

Addendum charts0

VolumeSEEEEEEEEEEEEEEEEEEEEEE

20162019202120242026

30.040.050.060.070.080.090.00100.0M200.0M$68.71

2026-10-27

Price$68.71

MA20$65.05

MA50$49.41

Vol27.2M

What would $1,000 invested in CNC be worth today? →

CNC returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $68.71
YTD price return: +66.97%
YTD total return: +66.97%
Market cap: 34B2016-12 9.7B2026-10 34.1B+252.7% over the window
Enterprise value: 26.8B
Shares outstanding: 495.1M2016-09 341.8M2026-09 495.1M+44.8% over the window
52W low: $31.63
52W high: $72.50
From 52W high: -5.23%
From 52W low: +117.23%
52W range: 91%
Beta: 1.09

Volume

Rel volume: 2.40×
30D volume: 4.9M
30D $ vol: 321.3M

Insider trading

Insider net 1WNo open-market insider purchase or sale with a transaction date in the last 7 days, as filed on Form 4.: none
Insider net 1MNo open-market insider purchase or sale with a transaction date in the last 30 days, as filed on Form 4.: none
Insider net 3M0 insider-days of buying (no priced lot) and 2 of selling ($6.9M) in the last 91 days, by transaction date, open-market transactions only — awards, exercises, tax withholding and employee-plan purchases are not counted. A Form 4 is filed within two business days of the trade, so the newest days may not be in yet.: −$6.9M
Insider net 1Y0 insider-days of buying (no priced lot) and 3 of selling ($12.1M) in the last 365 days, by transaction date, open-market transactions only — awards, exercises, tax withholding and employee-plan purchases are not counted. A Form 4 is filed within two business days of the trade, so the newest days may not be in yet.: −$12.1M

Form 4 transactions by trade date, as filed; latest on file 2026-08-26.

Fundamentals

Sales (ttm): 203.9B2016-09 35B2026-09 203.9B+482.6% over the window
Sales/share: $411.852016-09 $102.402026-09 $411.85+302.2% over the window
EPS (ttm): $2.952016-09 $1.292026-09 $2.95+128.8% over the window
FCF (ttm): 3.9B2016-09 200M2026-09 3.9B+1871.5% over the window
FCF/share: $7.962016-09 $0.592026-09 $7.96+1261.1% over the window
Book value/share: $44.862016-09 $16.712026-09 $44.86+168.5% over the window
Net margin: 0.72%2016-09 1.2%2026-09 0.7%-39.2% over the window
ROE: 6.57%2016-09 7.2%2026-09 6.6%-8.9% over the window
ROA: 1.84%2016-09 2.1%2026-09 1.8%-12.2% over the window
Debt / equity: 0.70×2016-09 0.662026-09 0.70+6.1% over the window
Current ratio: 1.162016-09 0.862026-09 1.16+35.4% over the window

Growth (CAGR, ttm) · 10Y

Sales: +9.71%2025-09-30 → 2026-09-30185.9B → 203.9B (+9.7% total)+10.75%2023-09-30 → 2026-09-30150.1B → 203.9B (+35.8% total)+10.87%2021-09-30 → 2026-09-30121.7B → 203.9B (+67.5% total)+19.27%2016-09-30 → 2026-09-3035B → 203.9B (+482.6% total)
Net income: n/a-15.78%2023-09-30 → 2026-09-302.4B → 1.5B (-40.3% total)+14.68%2021-09-30 → 2026-09-30736M → 1.5B (+98.4% total)+13.49%2016-09-30 → 2026-09-30412M → 1.5B (+254.4% total)
FCF: +17.50%2025-09-30 → 2026-09-303.4B → 3.9B (+17.5% total)-10.23%2023-09-30 → 2026-09-305.5B → 3.9B (-27.7% total)-6.92%2021-09-30 → 2026-09-305.6B → 3.9B (-30.1% total)+34.74%2016-09-30 → 2026-09-30200M → 3.9B (+1871.5% total)
Shares: +0.72%2025-09-30 → 2026-09-30491.5M → 495.1M (+0.7% total)-2.50%2023-09-30 → 2026-09-30534.2M → 495.1M (-7.3% total)-3.23%2021-09-30 → 2026-09-30583.5M → 495.1M (-15.2% total)+3.78%2016-09-30 → 2026-09-30341.8M → 495.1M (+44.8% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: n/a-12.59%2023-09-30 → 2026-09-30$4.42 → $2.95 (-33.2% total)+18.72%2021-09-30 → 2026-09-30$1.25 → $2.95 (+135.8% total)+8.63%2016-09-30 → 2026-09-30$1.29 → $2.95 (+128.8% total)
Sales/share: +8.93%2025-09-30 → 2026-09-30$378.13 → $411.85 (+8.9% total)+13.59%2023-09-30 → 2026-09-30$280.98 → $411.85 (+46.6% total)+14.58%2021-09-30 → 2026-09-30$208.57 → $411.85 (+97.5% total)+14.94%2016-09-30 → 2026-09-30$102.40 → $411.85 (+302.2% total)
FCF/share: +16.66%2025-09-30 → 2026-09-30$6.83 → $7.96 (+16.6% total)-7.93%2023-09-30 → 2026-09-30$10.20 → $7.96 (-21.9% total)-3.81%2021-09-30 → 2026-09-30$9.67 → $7.96 (-17.6% total)+29.84%2016-09-30 → 2026-09-30$0.59 → $7.96 (+1261.1% total)
Book value/share: +5.25%2025-09-30 → 2026-09-30$42.62 → $44.86 (+5.2% total)-1.79%2023-09-30 → 2026-09-30$47.35 → $44.86 (-5.3% total)-0.22%2021-09-30 → 2026-09-30$45.36 → $44.86 (-1.1% total)+10.38%2016-09-30 → 2026-09-30$16.71 → $44.86 (+168.5% total)
Price: +107.37%2025-10-27 → 2026-10-27$33.15 → $68.71 (+107.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+0.60%2023-10-27 → 2026-10-27$67.48 → $68.71 (+1.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-0.53%2021-10-27 → 2026-10-27$70.55 → $68.71 (-2.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+7.95%2016-10-26 → 2026-10-27$31.98 → $68.71 (+114.9% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +107.37%2025-10-27 → 2026-10-27$33.15 → $68.71 (+107.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+0.60%2023-10-27 → 2026-10-27$67.48 → $68.71 (+1.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-0.53%2021-10-27 → 2026-10-27$70.55 → $68.71 (-2.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+7.95%2016-10-26 → 2026-10-27$31.98 → $68.71 (+114.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 23.3×2016-12 23.442026-10 23.33-0.5% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 33.8×2016-12 10.072026-10 33.82+235.9% over the window
Fwd P/E: 13.1×
P/S (ttm)Market cap ÷ TTM revenue.: 0.2×2016-12 0.282026-10 0.17-39.5% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 1.5×2016-12 1.692026-10 1.53-9.3% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 8.6×2016-12 48.292026-10 8.64-82.1% over the window
EV/EBITDA (fy): 12.0×
EV/Sales (ttm): 0.1×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 11.59%2016-09 2.1%2026-09 12.8%+519.1% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-09-30) ÷ shares_at(2025-09-30) = 1 − 495.1M ÷ 491.5M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: -0.72%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-0.72%) + dividends paid over that year ($0) ÷ market_cap_at(2025-09-30) ($17.5B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: -0.72%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($25M) ÷ today's market cap ($34B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 0.07%2016-09 0.8%2026-09 0.1%-89.2% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $25M + TTM dividends $0) ÷ today's market cap ($34B). Same caveat as the cash buyback yield.: 0.07%2016-09 0.8%2026-09 0.1%-89.2% over the window

Vs own 10Y history

P/E: 62nd
P/OI: 98th
P/S: 14th
P/B: 44th
P/FCF: 45th

Bar = where today’s multiple sits in CNC’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-27#

+1.00%

-2.97%

+11.15%

+7.23%

YTD

+66.97%

+107.27%

-2.61%

Recent filings#

Oct 27Earnings · Earnings release — EPS $0.50 vs $0.07 est.; revenue $50.65B (+2% y/y)
Aug 26Insider sale · KOSTER CHRISTOPHER (Secretary & General Counsel) sold 104,103 shares for $6.9M on 2 days since Aug 18
Aug 178-K · CENTENE ANNOUNCES PLANNED CHIEF FINANCIAL OFFICER TRANSITION
Jul 28Earnings · Earnings release — EPS $2.51 vs $0.89 est. (+182.0%); revenue $53.58B (+10% y/y)

All filings and insider trades →

Financial statements

Open full CNC financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+8.32%	+0.22%
JNJ	Johnson & Johnson	-0.92%	+0.91%
ABBV	AbbVie Inc.	+8.34%	-0.12%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+8.98%	-0.08%
MRK	Merck & Co. Inc.	-4.68%	+0.86%
NVS	Novartis AG	+7.84%	+1.98%
TMO	Thermo Fisher Scientific Inc.	+2.67%	+1.19%
AMGN	Amgen Inc.	+8.04%	+0.75%

CNC — Centene Corporation price, chart and key statistics